Semantic Scholar uses AI to extract papers important to this topic.
Current therapeutic options for Chagas' disease are limited to benznidazole and nifurtimox, which have been associated… Expand
An increase in the frequency of azole-resistant Aspergillus fumigatus has emerged.
Patients with neutropenia resulting from chemotherapy for acute myelogenous leukemia or the myelodysplastic syndrome… Expand BACKGROUND
Invasive fungal infections are an important cause of morbidity and mortality after allogeneic hematopoietic stem-cell… Expand BACKGROUND
Invasive aspergillosis is an important cause of morbidity and mortality in immunocompromised patients. Current… Expand To evaluate the activity of posaconazole for treatment of zygomycosis, a disease for which therapeutic options are limited, we… Expand ABSTRACT Zygomycosis, an infection that is associated with significant morbidity and mortality, is becoming common in… Expand BACKGROUND
Conventional amphotericin B-based antifungal therapy for invasive fusariosis in patients with a hematologic malignancy… Expand ABSTRACT The in vitro activity of the novel triazole antifungal agent posaconazole (Noxafil; SCH 56592) was assessed in 45… Expand AIMS
This randomized, crossover, single-dose study evaluated the relative oral bioavailability of posaconazole suspension and… Expand